Sweden's Meda snaps up Acton for $200M; GSK wins EU nod on Tafinlar; Lundbeck to appeal €94M antitrust fine;

@FiercePharma: Executives' TV confessions in China are A) suspect, and B) a disturbing trend. More | Follow @FiercePharma

@EricPFierce: A court-appointed receiver is selling off equipment, patents from failed biosimilars plant. More from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: Vivus CEO resigns after one month on the job; forner J&J exec Seth H. Z. Fischer appointed. Release | Follow @CarlyHFierce

> Sweden's Meda has agreed to buy Acton Pharmaceuticals, a Massachusetts-based drugmaker that recently won approval for a new asthma treatment, in a $200 million deal. Report

> GlaxoSmithKline ($GSK) nabbed European approval for its new melanoma treatment Tafinlar. Release

> Denmark's Lundbeck said it would appeal a €94 million fine levied by EU antitrust authorities, citing important errors in the case. Report

> A bankruptcy judge appropved KV Pharmaceutical's reorganization plan; the drugmaker filed for bankruptcy protection last August. Report

> Novartis ($NVS) won European approval for its anti-inflammatory drug Ilaris for children with systemic juvenile idiopathic arthritis. Release

> Roche's ($RHHBY) new subcutaneous formula of its breast cancer drug Herceptin won approval in Europe. Report

> Chile's CFR Pharmaceuticals said it will decide within weeks whether to make a binding offer for South Africa's Adcock Ingram. Report

> Boehringer Ingelheim's inhaler device Respimat is as safe and effective for patients with chronic obstructive pulmonary disease (COPD) as its older HandiHaler, a study found. Report

Medical Device News

@FierceMedDev: Device companies seek legal advice as Chinese corruption crackdown carries on. Item | Follow @FierceMedDev

@MarkHFierce: Medtronic is already rolling out its hospital solutions/consulting business. Diversification proceeds in earnest. Release | Follow @MarkHFierce

@MichaelGFierce: ICYMI: European public health group gets behind tighter device controls. Item | Follow @MichaelGFierce

> Echo Therapeutics' largest shareholder urges rapid reforms. Article

> Taiwan to tackle device industry R&D, training incentives. Story

> Medtronic debuts health services arm. More

Biotech News

@FierceBiotech: ICYMI: Merck triggers patent war with Gilead over sofosbuvir rights. Story | Follow @FierceBiotech

@JohnCFierce: Schoenbaum's take on Amgen's demand for unblinded Kyprolis trial data: Poker move by Bradway to drop the price. | Follow @JohnCFierce

@RyanMFierce: ICYMI: Start-Up mag covered the trend of VC investments in clinical trials at major pharmas like Pfizer back in April. More | Follow @RyanMFierce

> U.K.'s Acacia banks $23.5M for PhIII drug to support cancer patients. Article

> PhII flop clouds future of Amgen, Cytokinetics heart failure drug. News

> Waksal brushes off jail time, plots biotech IPOs in a red-hot market. More

Pharma Manufacturing News

> Cubist recalls four lots of flagship antibiotic. More

> Quality issue keeps Apricus Biosciences from getting Swiss approval for Vitaros. Story

> Receiver selling off equipment, IP from failed biosimilars project. Article

> Hospira recalls product after hair found in one injector. News

> GSK gets interest from buyers for Romania plant. More

> India OKs Wockhardt plant banned by FDA. Report

Biotech Research News

@EmilyMFierce: Former cancer drug could treat diabetes, autoimmune diseases. More | Follow @EmilyMFierce

> Johnson & Johnson forges partnership to fight dengue fever. Article

> High blood pressure therapy speeds TB recovery. News

> Altered gene in mice extends lifespan by 20%. Report

> New opioid pain drug decreases tolerance, side effects. Story

> Worm genome reveals possible drug targets. Item

CRO News

> PPD snags Acurian for recruitment software. News

> CMO Lonza lopping off hundreds of jobs. More

> Duke's CRO nabs another trial deal. Story

> Psi expands in Italy amid global push. Report

> Report: Big CROs soared 10% last year. Article

Biotech IT News

> DNA software startup Desktop Genetics scores £375K in early funding. More

> Report: BGI readies for big genomics IPO. More

> Eagle Genomics captures £590,000 round to feed bioinformatics biz. Article

> AstraZeneca backs web portal for breast cancer docs. Story

> Quantia, provider of software to pharma, lands $10M B round. Item

> Eli Lilly, Humana partner on crunching diabetes data. Article

And Finally... The art and science of the power nap. Report